who should not use tirzepatide The hidden risks of GLP-1 weight loss prescriptions Who Should NOT Take GLP-1

This approval follows data from the STEP UP trial, which indicated that the gher dose led to a significant weight loss of 18.7% compared to 3.9% for placebo, with some participants achieving over 25% weight loss

Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings

It helps the skin retain moisture and improves its barrier function, which in turn enhances the skin's texture, giving it a smooth and even look

The first group had the lowest mean weight loss of 9.2% at 176 weeks

When combined with a functional medicine approach, they become a tool for sustainable transformation